Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-05, Stock:JNJ, The news for the past five days is as follows:
2019-01-29: NEWS1: Health Care Sector Update for 01/29/2019: JNJ,CGC,WEED.TO,BIIB,AGN.NEWS2: Health Care Sector Update for 01/29/2019: JNJ,CGC,WEED.TO,BIIB,AGN.NEWS3: Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y.NEWS4: Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y.NEWS5: U.S. senator asks J&J for documents on talc, baby powder safety.NEWS6: U.S. senator asks J&J for documents on talc, baby powder safety.NEWS7: The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Starbucks, Norfolk and Prologis.NEWS8: The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Starbucks, Norfolk and Prologis.NEWS9: Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y.NEWS10: AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting.NEWS11: AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting.NEWS12: Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips.NEWS13: Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips.NEWS14: The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Starbucks, Norfolk and Prologis.NEWS15: Health Care Sector Update for 01/29/2019: ARAY, TRVN, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Health Care Sector Update for 01/29/2019: ARAY, TRVN, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips.NEWS18: AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting.NEWS19: 3 Stocks Warren Buffett Might Sell Next.NEWS20: 3 Stocks Warren Buffett Might Sell Next.NEWS21: 3 Stocks Warren Buffett Might Sell Next.NEWS22: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS23: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.
2019-01-30: NEWS1: Roche Halts Two Late-Stage Studies on Alzheimer's Candidate.NEWS2: Roche Halts Two Late-Stage Studies on Alzheimer's Candidate.NEWS3: Roche Halts Two Late-Stage Studies on Alzheimer's Candidate.NEWS4: Johnson & Johnson Forecasts Modest EPS Growth for Fiscal 2019.NEWS5: Yacktman Fund's 4th Quarter Shareholder Commentary.NEWS6: What Are Johnson & Johnson’s Revenue Forecasts for Fiscal 2019?.NEWS7: What Analysts Recommend for Johnson & Johnson after Q4 Results.NEWS8: 3 Big Pharmas Expecting a Softer 2019.NEWS9: 3 Big Pharmas Expecting a Softer 2019.NEWS10: Health Care Sector Update for 01/30/2019: CODX, ANTM, ACIU, JNJ, PFE, MRK, ABT, AMGN.NEWS11: Health Care Sector Update for 01/30/2019: CODX, ANTM, ACIU, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for January 31, 2019.NEWS13: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for January 31, 2019.NEWS14: 3 Big Pharmas Expecting a Softer 2019.NEWS15: Better Buy: Johnson & Johnson vs. Pfizer.NEWS16: Better Buy: Johnson & Johnson vs. Pfizer.NEWS17: Better Buy: Johnson & Johnson vs. Pfizer.
2019-01-31: NEWS1: 7 Blue-Chip Stocks That Could Lead the Market Higher.NEWS2: 7 Blue-Chip Stocks That Could Lead the Market Higher.NEWS3: 5 Top Gainers In Healthcare Sector (NVUS, MGTX, APHA...).NEWS4: 5 Top Gainers In Healthcare Sector (NVUS, MGTX, APHA...).NEWS5: Here Are Some Possible Headwinds and Tailwinds for JNJ in 2019.NEWS6: Health Care Sector Update for 01/31/2019: SCYX, PULM, BAX, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 01/31/2019: SCYX, PULM, BAX, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Johnson & Johnson to Focus on Increasing Research and Development.NEWS9: What Analysts Project for JNJ’s Margins and Interest Expenses.NEWS10: Exclusive: Sri Lanka halts imports of Johnson & Johnson Baby Powder pending asbestos tests.NEWS11: Exclusive: Sri Lanka halts imports of Johnson & Johnson Baby Powder pending asbestos tests.NEWS12: The Value of Patience: Cramer's 'Mad Money' Recap (Wednesday 1/30/19).
2019-02-01: NEWS1: Merck (MRK) Beats on Q4 Earnings & Sales as Keytruda Shines.NEWS2: Merck (MRK) Beats on Q4 Earnings & Sales as Keytruda Shines.NEWS3: Merck (MRK) Beats on Q4 Earnings & Sales as Keytruda Shines.NEWS4: Health Care Sector Update for 02/01/2019: TTNP, CTIC, OPK, JNJ, PFE, MRK, ABT, AMGN.NEWS5: Health Care Sector Update for 02/01/2019: TTNP, CTIC, OPK, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS7: Watch These Healthcare Stocks in First Week of February.NEWS8: A Look at Johnson & Johnson’s Dividends and Share Repurchases.NEWS9: Missouri Supreme Court suspends second talc cancer trial in weeks.NEWS10: J&J's Erleada Meets Both Primary Endpoints in Late-Stage Study.NEWS11: J&J's Erleada Meets Both Primary Endpoints in Late-Stage Study.NEWS12: 9 Best Dividend Stocks to Buy for Every Investor.NEWS13: 9 Best Dividend Stocks to Buy for Every Investor.NEWS14: J&J's Erleada Meets Both Primary Endpoints in Late-Stage Study.
2019-02-04: NEWS1: U.S. Senate panel invites seven drug companies to testify on drug costs.NEWS2: What Are Analysts Recommending for Merck after Q4 2018 Results?.NEWS3: J&J Reportedly Agrees To Resolve Most Pinnacle Hip-Device Lawsuits.NEWS4: J&J Reportedly Agrees To Resolve Most Pinnacle Hip-Device Lawsuits.NEWS5: Celgene Highlights What Bristol-Myers Squibb Is Getting.NEWS6: Celgene Highlights What Bristol-Myers Squibb Is Getting.NEWS7: Celgene Highlights What Bristol-Myers Squibb Is Getting.NEWS8: Better Buy: Johnson & Johnson vs. Merck & Co..NEWS9: Better Buy: Johnson & Johnson vs. Merck & Co..NEWS10: Health Care Sector Update for 02/04/2019: BLRX, EOLS, FENC, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 02/04/2019: BLRX, EOLS, FENC, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Better Buy: Johnson & Johnson vs. Merck & Co..NEWS13: Johnson & Johnson Vision Announces Availability in Europe of TECNIS Eyhance IOL, a Next-Generation Monofocal Intraocular Lens for Patients with Cataracts.

Answer: Rise